Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04397029 · ClinicalTrials.gov registry record · NA
Assessing the Sensitivity of "SureTouch™" in Women Undergoing Diagnostic and Screening Mammography
A NA study, sponsored by George Washington University.
- Terminated
- Registry status
- NA
- Development phase
- 213
- Enrollment target
NCT04397029: Clinical Trial NA study, sponsored by George Washington University.
NCT04397029 is a NA study that was terminated before completion, run by George Washington University. The registered enrollment target is 213 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04397029, a NA study, was terminated before completion, sponsored by George Washington University.
- TERMINATED
- Registry status
- NA
- Development phase
- 213 participants
- Enrollment target
Study Summary
Prospective, case-control study being conducted to determine the sensitivity of the SureTouch device in detecting known masses at a pre-determined level of specificity.
Primary Outcome
1\. This study examines the sensitivity of the SureTouch™ system, compared with methods that are the current standard of care (screening and diagnostic mammography with ultrasound), to detect clinically significant mass lesions in the breast.
Interventions
- DEVICE SureTouch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 213 participants |
| Start Date | 2019-01-04 |
| Est. Completion | 2021-02-10 |
| Phase | NA |
Why NCT04397029 stopped before completion
NCT04397029 is an interventional study that assigns participants to a tested intervention. The registered 213 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 1 intervention - of which SureTouch is the first listed.
NCT04397029 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04397029 about?
NCT04397029 is a clinical study titled "Assessing the Sensitivity of "SureTouch™" in Women Undergoing Diagnostic and Screening Mammography". Prospective, case-control study being conducted to determine the sensitivity of the SureTouch device in detecting known masses at a pre-determined level of specificity.
What is the current status of trial NCT04397029?
This trial is currently terminated. It is a NA study. The enrollment target is 213 participants. The study started on 2019-01-04. Estimated completion is 2021-02-10.
What interventions are being tested in trial NCT04397029?
The interventions under investigation include: SureTouch (DEVICE).
Who is sponsoring clinical trial NCT04397029?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04397029's enrollment target sits among peer trials
213 488th of 2000 higher than 1,512 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06476886 · 213 participants · NA
Intensive Crisis Intervention
- NCT06544655 · 213 participants · Phase 1
A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
- NCT07186816 · 213 participants · NA
SUpport From PEeRs to Expand Access Study - Community
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI